TrialAdvances in therapy2025

Safety, Tolerability, and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients with Focal-Onset Seizures: Interim Analysis of a Phase 3 Open-Label Extension Trial.

Ayataka Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.